Document is current
Any future updates will be listed below
-
Authors
Omole, Anthony O. https://orcid.org/0000-0002-2323-2790
Affonso de Oliveira, Jessica Fernanda
Sutorus, Lucas https://orcid.org/0000-0001-7380-1843
Karan, Sweta
Zhao, Zhongchao
Neun, Barry W.
Cedrone, Edward
Clogston, Jeffrey D. https://orcid.org/0009-0003-6150-3904
Xu, Jie
Sierk, Michael https://orcid.org/0000-0002-0657-0288
Chen, Qingrong
Meerzaman, Daoud
Dobrovolskaia, Marina A. https://orcid.org/0000-0002-4233-9227
Steinmetz, Nicole F. https://orcid.org/0000-0002-0130-0481
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA253615, R01 CA274640)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (75N91010D00024)
American Cancer Society (MBGI-23-1030244-01-MBG)
Alfred P. Sloan Foundation (G-2020-14067)
- License Information
-
More Information
Article History
Received: 20 February 2024
Accepted: 28 September 2024
First Online: 24 October 2024
Competing interests
: The authors declare the following competing financial interest(s): Dr. Steinmetz is a co-founder and CEO of and has equity in PlantiosX Inc. Dr. Steinmetz is a co-founder of and has equity in Mosaic ImmunoEngineering Inc. Dr. Steinmetz is a co-founder and manager of Pokometz Scientific LLC, under which she is a paid consultant to Flagship Labs 95 Inc. and Arana Biosciences Inc. The other authors declare no potential COI.
